Press "Enter" to skip to content

Lupin receives tentative U.S. FDA approval for Mirabegron ER Tablets

Pharma major Lupin Limited (Lupin) announced that it has received tentative approval for its Mirabegron Extended Release (ER) Tablets, 25 mg and 50 mg, from the USFDA

Original source:

Also Read:   Zydus receives final nod from USFDA to market Acetazolamide injection